Beyond its effects on neuroinflammation, AZD8797 suppresses CX3CR1-positive monocyte-mediated tumor growth in chronic lymphocytic leukemia (CLL) cells (Zhong W, 2024). The gene discussed is CX3CR1; the disease is B-cell chronic lymphocytic leukemia.